CTSO
Cytosorbents Corp SEC filings
Every EDGAR filing for Cytosorbents Corp (CTSO), newest first, with AI summaries and stories.
- Ticker
- CTSO
- CIK
- 1175151
- Sector
- Medical devices
- Latest filing
- Sep 23
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 10 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KCytosorbents CorpCTSOLIVE ROUTINE4Cytosorbents CorpCTSOLIVE Phillip P. Chan, insider filing for CTSO
Phillip P. Chan, reporting
ROUTINE4Cytosorbents CorpCTSOLIVE 2 insider filings
Alan D. Sobel, insider filing for CTSO
Show all 2
- 4Insider filing for CTSO
- 4Insider filing for CTSO
Alan D. Sobel, reporting
ROUTINE4Cytosorbents CorpCTSOLIVE Phillip P. Chan, insider filing for CTSO
Phillip P. Chan, reporting
ROUTINE8-KCytosorbents CorpCTSOLIVE ROUTINE8-KCytosorbents CorpCTSOLIVE ROUTINE8-KCytosorbents CorpCTSOLIVE ROUTINE8-KCytosorbents CorpCTSOLIVE NOTABLE10-QCytosorbents CorpCTSOLIVE ROUTINE8-KCytosorbents CorpCTSOLIVE ROUTINEARSCytosorbents CorpCTSOLIVE ROUTINEDEFA14ACytosorbents CorpCTSOLIVE ROUTINEDEF 14ACytosorbents CorpCTSOLIVE ROUTINE8-KCytosorbents CorpCTSOLIVE ROUTINE4Cytosorbents CorpCTSOLIVE Peter J Mariani, insider filing for CTSO
Peter J Mariani, reporting
ROUTINE4Cytosorbents CorpCTSOLIVE Phillip P. Chan, insider filing for CTSO
Phillip P. Chan, reporting
ROUTINEPRE 14ACytosorbents CorpCTSOLIVE NOTABLE10-QCytosorbents CorpCTSOLIVE ROUTINE8-KCytosorbents CorpCTSOLIVE ROUTINE10-K/ACytosorbents CorpCTSOLIVE ROUTINE8-KCytosorbents CorpCTSOLIVE NOTABLE10-KCytosorbents CorpCTSOLIVE ROUTINE8-KCytosorbents CorpCTSOLIVE ROUTINESCHEDULE 13G/ACytosorbents CorpCTSOLIVE Ownership stake disclosure by AVENIR CORP (amended)
AVENIR CORP, filed by
ROUTINE4Cytosorbents CorpCTSOLIVE Cytosorbents Corp - Insider ownership filing (4)
- Insider ownership filing (4)
- Reports beneficial ownership changes
Phillip P. Chan, reporting
MAJOR8-KCytosorbents CorpCTSOLIVE Cytosorbents Corp (CTSO) announced the resignation of its Chief Financial Officer, effective immediately, citing personal reasons. This leadership change comes at a critical time as the company navigates ongoing challenges in its medical device business, which could impact…
NOTABLE10-QCytosorbents CorpCTSOLIVE Cytosorbents Corp. (CTSO) filed its Q3 2025 quarterly report (Form 10-Q), providing investors with an update on the company's financial performance and operational status.